Jyrarque
Ended Awarded Last action
- Contract number
- 36C26124N0274
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $37,030
Award facts
- Contract value 100% obligated
- $37,029.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $356 | |
| Original award | $36,674 |
About this award
Otsuka America Pharmaceutical Inc. received a delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) valued at approximately $37K, awarded on November 22, 2023, with completion scheduled for January 22, 2024. This firm fixed-price delivery order, which utilized no set-aside designation, is issued under the company's larger Blanket Purchase Agreement for Jynarque (tolvaptan) on the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Jynarque is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veterans.
This delivery order represents one of multiple task orders issued to Otsuka America Pharmaceutical Inc. across various VA Integrated Service Networks to support the Veterans Health Administration's mission of providing specialized pharmaceutical treatments. The prime contractor maintains a substantial $83.3 million Blanket Purchase Agreement with the VA's National Acquisition Center for Jynarque, as well as an additional $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products. The VA relies on these Indefinite Delivery Vehicles to streamline procurement of critical medications for veterans across the nation, with the contract family supporting healthcare delivery in multiple service networks.
Quick answers
Who was awarded contract 36C26124N0274?
36C26124N0274 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on November 22, 2023.
How much is contract 36C26124N0274 worth?
The government has obligated $37,030 on 36C26124N0274.
Is contract 36C26124N0274 an order under another contract?
Yes. 36C26124N0274 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0274 competed?
The extent of competition for 36C26124N0274 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award